Klemp Walter V

Klemp Walter V is listed in filings as CEO and President at Moleculin Biotech, Inc.. This profile follows SEC Form 4 activity through Jun 24, 2026, including purchase activity. Recent filings connect the profile to Moleculin Biotech, Inc. (MBRX) and Autonomix Medical, Inc. Common Stock (AMIX). The current snapshot covers public activity from Jun 18, 2024 to Jun 24, 2026. Reported amounts are shown as $275 to $1.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.